Pulmonary Function Testing Devices Market Report
First published: 20 October 2024 | Last updated: 25 May 2026 | Report Code: pulmonary-function-testing-devices
Pulmonary Function Testing Devices Market — USD 1.5 billion in 2023, Growing to USD 2.67B by 2033 at 5.8% CAGR
This report provides a comprehensive analysis of the Pulmonary Function Testing Devices market, focusing on market size, growth trends, segmentation, regional insights, and technology advancements from 2023 to 2033.
Key Takeaways
- Market value rises from $1.50 Billion in 2023 to $2.67 Billion in 2033 at a 5.8% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe expands from $0.42 Billion in 2023 to $0.75 Billion in 2033, supported by diagnostic adoption.
- Technology shifts toward digital, portable, and wearable devices are reshaping product offerings and access to testing.
Pulmonary Function Testing Devices Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report outlines the Pulmonary Function Testing Devices market structure, drivers, and competitive dynamics from 2023 to 2033. The market, valued at $1.50 Billion in 2023 and forecast to reach $2.67 Billion by 2033 at a 5.8% CAGR, is supported by increasing respiratory disease prevalence, aging populations, and heightened diagnostic awareness. Advances in digital, portable, and wearable technologies are enabling broader deployment across hospitals, clinics, research labs, and home settings. Regional data show North America as the largest market, with notable growth also occurring in Europe, Asia Pacific, Latin America, and the Middle East and Africa. Leading companies profiled include CareFusion Corporation, Fukuda Sangyo Co., Ltd., MediSoft, Getinge Group, and Schiller AG. The report combines expert interviews, company disclosures, and triangulated secondary sources to map trends, segment performance, and opportunities for manufacturers, providers, and investors while highlighting regulatory and cost considerations that could influence adoption rates.
Key Growth Drivers
- Rising incidence of chronic respiratory illnesses increasing demand for diagnostic devices.
- Advances in digital and portable technologies improving accessibility and user convenience.
- Greater emphasis on preventive care and routine pulmonary monitoring across care settings.
- Expansion of home-based testing options enabling long-term patient monitoring and follow-up.
- Investment and R&D by established medical device manufacturers broadening product portfolios.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 5.8% |
| 2033 Market Size | $2.67 Billion |
| Top Companies | CareFusion Corporation, Fukuda Sangyo Co., Ltd., MediSoft, Getinge Group, Schiller AG |
| Published Date | 20 October 2024 |
| Last Modified Date | 25 May 2026 |
Pulmonary Function Testing Devices Market Overview
Customize Pulmonary Function Testing Devices Market Report market research report
- ✔ Get in-depth analysis of Pulmonary Function Testing Devices market size, growth, and forecasts.
- ✔ Understand Pulmonary Function Testing Devices's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Pulmonary Function Testing Devices
What is the Market Size & CAGR of Pulmonary Function Testing Devices Market Report market in 2023?
Pulmonary Function Testing Devices Industry Analysis
Pulmonary Function Testing Devices Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Pulmonary Function Testing Devices Market Report Market Analysis Report by Region
Europe Pulmonary Function Testing Devices Market Report:
Europe grows from $0.42 Billion in 2023 to $0.75 Billion in 2033. Regional expansion is driven by widespread clinical adoption, growing awareness of early diagnosis, and integration of digital pulmonary testing solutions.Asia Pacific Pulmonary Function Testing Devices Market Report:
Asia Pacific grows from $0.3 Billion in 2023 to $0.54 Billion in 2033. Market momentum stems from rising respiratory disease incidence, improving healthcare access, and increasing acceptance of portable and home-use devices.North America Pulmonary Function Testing Devices Market Report:
North America is largest regional market, rising from $0.49 Billion in 2023 to $0.87 Billion in 2033. Growth is supported by advanced healthcare infrastructure, high diagnostic uptake in hospitals and clinics, and investments by major device manufacturers.South America Pulmonary Function Testing Devices Market Report:
Latin America grows from $0.08 Billion in 2023 to $0.13 Billion in 2033. Demand is influenced by greater diagnostic awareness, gradual healthcare investment, and the emergence of more accessible testing technologies.Middle East & Africa Pulmonary Function Testing Devices Market Report:
Middle East and Africa grows from $0.21 Billion in 2023 to $0.37 Billion in 2033. Growth factors include expanding healthcare services, heightened focus on respiratory health, and adoption of compact testing solutions.Tell us your focus area and get a customized research report.
Research Methodology
Pulmonary Function Testing Devices Market Analysis By Product Type
The product type segment reveals that spirometers lead the market, with a size of $0.84 billion in 2023, projected to reach $1.49 billion by 2033. Peak flow meters follow at $0.32 billion (2023) to $0.56 billion (2033), while body plethysmographs and gas exchangers represent smaller market shares, yet show significant growth potential in niche applications.
Pulmonary Function Testing Devices Market Analysis By Application Area
In terms of application, diagnostic applications dominate the market, expected to grow from $0.84 billion in 2023 to $1.49 billion by 2033. This is closely followed by therapeutic applications, which will grow to $0.56 billion, highlighting the continuous need for effective treatment approaches in managing respiratory disorders. Research and home care applications also demonstrate promising growth.
Pulmonary Function Testing Devices Market Analysis By End User
Hospitals account for the largest market share at 55.79% in 2023, with a market size of $0.84 billion, projected to reach $1.49 billion by 2033. Clinics and research laboratories also represent significant shares at 21.05% and 13.04%, respectively, while the home user sector is increasingly capturing interest due to a rising trend in home healthcare.
Pulmonary Function Testing Devices Market Analysis By Technology
The technology segment is dominated by traditional technology, with a market size of $0.84 billion in 2023, and is expected to grow to $1.49 billion by 2033. Digital technology holds a significant share, reflecting the industry's shift towards advanced digital diagnostics. Portable and wearable technologies are gaining traction as they allow for greater patient adherence and real-time data collection.
Pulmonary Function Testing Devices Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Pulmonary Function Testing Devices Industry
CareFusion Corporation:
A leading manufacturer of innovative respiratory devices, specializing in critical care and laparoscopic surgery products.Fukuda Sangyo Co., Ltd.:
Recognized for its contributions to pulmonary function testing equipment, focusing on enhancing diagnostic accuracy and patient comfort.MediSoft:
A key player in developing advanced pulmonary function testing solutions, known for its cutting-edge technology and integration capabilities.Getinge Group:
Engaged in advanced medical technology development to improve the quality of care in healthcare.Schiller AG:
A Swiss-based company specializing in medical devices, with a strong portfolio in respiratory diagnostic devices.We're grateful to work with incredible clients.
FAQs
What is the market size of the Pulmonary Function Testing Devices market in 2023?
The market size in 2023 is $1.50 Billion according to the report's input data, representing the base year for the 2023 to 2033 forecast period.
How big will the Pulmonary Function Testing Devices market be in 2033?
By 2033 the market is projected to reach $2.67 Billion as provided in the input data, reflecting growth across regions and technologies during the forecast window.
What is CAGR for the forecast period?
The report specifies a compound annual growth rate (CAGR) of 5.8% for the 2023 to 2033 forecast period.
Is there a single fastest Growing region in the Pulmonary Function Testing Devices Market Report market?
No single fastest-growing region is stated for the Pulmonary Function Testing Devices Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which region is the largest market?
North America is identified as the largest regional market, rising from $0.49 Billion in 2023 to $0.87 Billion in 2033 per the provided data.
Who are the top companies in this market?
Top companies listed in the input include CareFusion Corporation, Fukuda Sangyo Co., Ltd., MediSoft, Getinge Group, and Schiller AG.
Why are digital and portable technologies important?
Digital and portable devices increase accessibility, enable real-time data, support home monitoring, and encourage broader adoption across care settings according to the contextual trends.
How is the market segmented by end User and technology?
Reported subsegments include Hospitals, Clinics, Research Laboratories, Home Users for end-user and Traditional, Digital, Portable, Wearable technologies for technology categorization.